Aldesleukin Completed Phase 1 / 2 Trials for Malignant Lymphomas Treatment

IndicationsStatusPurposePhase
CompletedTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs
NCT00182650Cellular Adoptive Immunotherapy in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin's Lymphoma
NCT00058045Interleukin-2 and Stem Cell Factor in Treating Patients With AIDS or AIDS-Related Cancer
NCT00020462Vaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III, Stage IV, or Recurrent Follicular Lymphoma
NCT00002687Interleukin-2 in Treating Patients With Mycosis Fungoides